Prevention of transfusion-transmitted cytomegalovirus in low-birth weight infants (≤1500 g) using cytomegalovirus-seronegative and leukoreduced transfusions.
about
Leucoreduction of blood components: an effective way to increase blood safety?Recommendations for transfusion therapy in neonatologyPrevention of Transfusion-Transmitted Cytomegalovirus Infections: Which is the Optimal Strategy?Distinct differences in platelet production and function between neonates and adults: implications for platelet transfusion practice.Blood transfusion and breast milk transmission of cytomegalovirus in very low-birth-weight infants: a prospective cohort study.Association of Red Blood Cell Transfusion, Anemia, and Necrotizing Enterocolitis in Very Low-Birth-Weight InfantsCytomegalovirus infection among infants in California neonatal intensive care units, 2005-2010How we decide when a neonate needs a transfusion.Postnatal cytomegalovirus infection: a pilot comparative effectiveness study of transfusion safety using leukoreduced-only transfusion strategy.The residual risk of transfusion-transmitted cytomegalovirus infection associated with leucodepleted blood components.New insights for preventing transfusion-transmitted cytomegalovirus and other white blood cell-associated viral infections.The contributions of red blood cell transfusion and severe anemia in necrotizing enterocolitis: causes or confounders?Sequence analysis of two variable cytomegalovirus genes for distinction between transfusion- and breast milk-transmitted infections in a very-low-birthweight infant.The impact of donor cytomegalovirus DNA on transfusion strategies for at-risk patients.
P2860
Q26771857-7622000A-2CFD-4956-9176-18EC359ED790Q26786617-4B1412D7-8D08-456C-9DA6-E21A2A76D6B7Q27005922-E3C913B3-FAA5-4E5B-A859-E93B70817110Q33409352-13ADB079-B2A1-4DDD-8E05-93FCA5CD36A2Q35350519-A7BC8026-278C-48DE-82C9-C47BD168FD56Q36722981-3875CB9C-A98F-4D3B-B71F-0DD46569B492Q36807473-1C9293F2-5CD1-4B80-855D-89B469CE95D5Q38055209-22CE22D4-F78C-433B-A5E2-BDCAD233288DQ39849819-747B0579-2D47-4F9E-B7C8-6BDF510A111CQ41100504-BDE29CF0-FBBA-40AA-9E3E-8364355092E9Q43956762-C3D58097-F2DD-47AF-B1FC-29D3F671B403Q50212677-351B28FC-3D1A-48FA-8E05-70E1B46AF51BQ50249183-E4F2DCEC-C324-4915-9809-ECEBFA32ED7FQ51818445-99ED9067-A708-4FA4-8BFA-540DC12B12C7
P2860
Prevention of transfusion-transmitted cytomegalovirus in low-birth weight infants (≤1500 g) using cytomegalovirus-seronegative and leukoreduced transfusions.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Prevention of transfusion-tran ...... and leukoreduced transfusions.
@ast
Prevention of transfusion-tran ...... and leukoreduced transfusions.
@en
type
label
Prevention of transfusion-tran ...... and leukoreduced transfusions.
@ast
Prevention of transfusion-tran ...... and leukoreduced transfusions.
@en
prefLabel
Prevention of transfusion-tran ...... and leukoreduced transfusions.
@ast
Prevention of transfusion-tran ...... and leukoreduced transfusions.
@en
P2093
P2860
P921
P1476
Prevention of transfusion-tran ...... and leukoreduced transfusions
@en
P2093
Angela M Caliendo
Cassandra D Josephson
Christopher D Hillyer
Edmund K Waller
John D Roback
Marta-Inés Castillejo
Michael Kutner
P2860
P304
P356
10.1016/J.TMRV.2010.11.004
P577
2011-02-23T00:00:00Z